Evidence map›Paper›PMID 30011286›Full record

ArticlePloS one2018

Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon.

Henry Dilonga Meriki, Kukwah Anthony Tufon, Damian Nota Anong, Nyeke James Tony, Tebit Emmanuel Kwenti, Ayah Flora Bolimo, Youmbi Sylvain Kouanou, Theresa Nkuo-Akenji

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Henry Dilonga MerikiDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.
Kukwah Anthony TufonDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.ORCID 0000-0002-5643-0515
Damian Nota AnongDepartment of Biological Science, Faculty of Science, University of Bamenda, Bamenda, North West Region, Cameroon.
Nyeke James TonyDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.
Tebit Emmanuel KwentiDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.ORCID 0000-0001-5526-9179
Ayah Flora BolimoBuea Regional Hospital, Buea, Southwest Region, Cameroon.
Youmbi Sylvain KouanouBuea Regional Hospital, Buea, Southwest Region, Cameroon.
Theresa Nkuo-AkenjiDepartment of Biological Science, Faculty of Science, University of Bamenda, Bamenda, North West Region, Cameroon.
University of Buea · CMUniversity of Bamenda · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHBV infection affects about 257 million people globally and Sub-Saharan Africa has the highest burden. The disease still constitutes a major public health problem despite the advent of preventive measures like the HBV vaccine. This study was aimed at identifying factors that influence vaccine uptake and the efficacy of administered vaccines among people at high risk of HBV infection.

methodsThis was a cross-sectional study conducted between January 2016 and December 2017. A pretested semi-structured questionnaire was used to capture information on sociodemographic and vaccination status from healthcare workers, household and sexual contacts to HBV infected people. HBV serological panel as well as quantitative anti-HBs ELISA test was done for all participants. Additional information was obtained from the institutions that administered the vaccines.

resultsA total of 265 participants with a mean age of 32.1±8.7 were enrolled. Eighty (30.2%) of them had received at least 1 dose of the HBV vaccine while 185 (69.8%) were unvaccinated. Healthcare workers were the most vaccinated (37%). Ignorance, negligence, fear of injection and the cost of the vaccine all contributed to poor vaccine uptake in the study population. Natural immunity was seen in 9 (3.4%) of the participants. Only 64.9% of the vaccinated participants attained the desirable level of anti-HBs (≥10mIU/ml) 1-2 months after ≥ 3 doses of the vaccine. Age, gender, obesity, alcohol and smoking were not significantly associated with poor immune responses. No standardized protocol was followed by the institutions administering the vaccine.

conclusionThis study revealed very poor vaccine uptake and poor immune responses to the HBV vaccine in the study population and this should urge the health sector in Cameroon to intensify their sensitization on HBV vaccine, standardize the protocol for storing and administering the vaccine, subsidize the cost of the vaccine especially amongst healthcare workers and encourage anti-HBs post vaccination testing.

Indexed as

FamilyHealth PersonnelSexual PartnersAdolescentAdultCameroonCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeHepatitis B, ChronicHepatitis B VaccinesHumansMiddle AgedRisk FactorsYoung AdultHepatitis B Vaccines

Identifiers

PMID30011286
PMCPMC6047772
OpenAlexW2884944234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.